2021 World Database of Blood Typing, Grouping and Infectious Disease NAT Screening Market-90-Countries-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

April 2021 | | ID: 2EBC70A0C47FEN
Venture Planning Group

Abstracts

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

This database from LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT

Geographic Regions and Countries

Asia-Pacific

Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam

Europe

Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia , Slovenia, Spain, Sweden, Switzerland, UK, Ukraine

Latin America

Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela

Middle East

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

North America

Canada, Mexico, USA

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET OVERVIEW

A. Business Environment
B. Market Structure

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

VI. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
  1. Blood Typing and Grouping Tests
    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh
    i. Other Blood Groups
  2. Infectious Disease Screening Tests
    a. AIDS/HIV
      Background
      Diagnostic Tests
        Enzyme Immunoassay
        Viral Load/Drug Resistance Testing
        Genotype and Phenotype Testing
      Blood Banking Considerations
    b. Hepatitis Markers
      Hepatitis A
      Hepatitis B
      Hepatitis C
      Hepatitis D (Delta Hepatitis)
      Hepatitis E
      Hepatitis G
      Vaccines and Drugs
    c. Cytomegalovirus
      Background
      Diagnostic Tests
      Vaccines and Drugs
    d. Syphilis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    e. West Nile Virus
      Background
      Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
    f. Parvovirus B19
      Microbiology
      Epidemiology
      Clinical Syndromes
      Diagnostic Test
      Vaccines and Drugs
    g. Creutzfeldt-Jakob’s Disease
      Background
      Transmission
      Diagnostic Tests
      Vaccines and Drugs
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  3. Pathogen Reduction
  4. Leukocyte Reduction
      Background
      Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Blood Typing, Grouping And Infectious Disease Screening Automated and Semiautomated Analyzers
C. Major Blood Banking Technologies and Their Potential Applications
  1. Molecular Diagnostics
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
  4. Microtitration Plates
  5. IT and Automation
  6. Lasers
  7. Robotics
  8. Synthetic Red Cell Substitutes
  9. Genetically Engineered Blood Components
  10. Blood Preservation
  11. Autologous Blood Transfusion/Freezing

VII. COUNTRY MARKET ANALYSES: BLOOD TYPING, GROUPING AND INFECTIOUS DISEASE SCREENING TEST VOLUME AND SALES FORECASTS FOR 90 COUNTRIES: ALBANIA, ARGENTINA, AUSTRALIA, AUSTRIA, BAHRAIN, BANGLADESH, BELARUS, BELGIUM, BOLIVIA, BRAZIL, BULGARIA, CANADA, CHILE, CHINA, COLOMBIA, COSTA RICA, CROATIA, CUBA, CYPRUS, CZECH REPUBLIC, DENMARK, DOMINICAN REPUBLIC, ECUADOR, EL SALVADOR, ESTONIA, FINLAND, FRANCE, GEORGIA, GERMANY, GREECE, GUATEMALA, HAITI, HONDURAS, HONG KONG, HUNGARY, ICELAND, INDIA, INDONESIA, IRAN, IRAQ, IRELAND, ISRAEL, ITALY, JAMAICA, JAPAN, JORDAN, KAZAKHSTAN, KUWAIT, LATVIA, LEBANON, LITHUANIA, MALAYSIA, MALTA, MEXICO, MOLDOVA, MYANMAR, NETHERLANDS, NEW ZEALAND, NICARAGUA, NORWAY, OMAN, PAKISTAN, PANAMA, PARAGUAY, PERU, PHILIPPINES, POLAND, PORTUGAL, PUERTO RICO, QATAR, ROMANIA, RUSSIA, SAUDI ARABIA, SERBIA, SINGAPORE, SLOVAK REPUBLIC, SLOVENIA, SOUTH KOREA, SPAIN, SWEDEN, SWITZERLAND, TAIWAN, THAILAND, UK, UKRAINE, UNITED ARAB EMIRATES, URUGUAY, USA, VENEZUELA, VIETNAM

VIII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher